Investigative Dossiers & Research Access
How readers, academic researchers, and partner newsrooms engage with klenfi’s investigative reporting.
Quarterly Investigative Dossiers
Comprehensive 15,000+ word reports detailing complex institutional matters, accompanied by verified source document repositories and timeline analysis.
Policy & Regulatory Briefings
Concise forensic dissections of emerging federal legislation, public procurement tenders, and corporate lobbying registries across Canada.
Open Document Repositories
Sanitized, verified primary records obtained through access-to-information filings, structured for civic researchers and non-profit partners.
Support independent reporting
We maintain full financial transparency. Our primary rate is set at 190 EUR annually.
Annual Patron & Dossier Access
Provides year-long digital access to all published investigative dossiers, primary document databases, and editorial briefings.
- Immediate access to all current and archived investigative dossiers
- Downloadable evidentiary exhibits and structured data files
- Quarterly editorial briefing memos written by our lead investigators
- Invitations to digital background Q&A sessions
- Individual non-commercial fair use citation rights
Newsroom Syndication Rights
For regional newspapers, independent broadcast outlets, and research think-tanks seeking republishing permissions.
- Republishing licenses for print and digital editions
- High-resolution investigative charts, photography, and infomaps
- Co-branded local data breakdowns available upon request
- Direct coordination with klenfi’s Ottawa reporting team
Republishing and Citation Guidelines
Non-profit organizations, independent journalists, and academic researchers may quote up to 250 words from any klenfi investigation under fair-dealing provisions without explicit prior written authorization, provided that clear attribution is given with a direct hyperlink to https://klenfi.pro/.
Full republication, serialization, or translation requires an active syndication agreement. To discuss terms, please write to [email protected].